Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Official title: To amend title XVIII of the Social Security Act to provide for extended months of Medicare coverage of immunosuppressive drugs for kidney transplant patients, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Placed on the Union Calendar, Calendar No. 570.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.
The Government Accountability Office must report on the bill's implementation.
- Introduced in House Formatted Text PDF Formatted XML
- Reported in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5534: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5534/
"H.R. 5534: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5534/.
H.R. 5534, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5534/.
[H.R. 5534: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020](https://openamerica.io/bill/116-HR-5534/)